The prevalence of obesity has grown to an alarming magnitude, affecting more than 300 million humans worldwide. Although in most instances obesity is caused by excessive caloric consumption, only recently have we begun to understand the mechanisms involved in the loss of balance between caloric intake and energy expenditure. In the hypothalamus, groups of specialized neurons provide the signals that, under physiological conditions, determine the stability of body mass. Recent studies have shown that under certain environmental and genetic conditions, this equilibrium is lost and body adiposity may increase. Here, we review the work that provided the basis for the current understanding of hypothalamic dysfunction and the genesis of obesity.
INTRODUCTION
Currently, obesity is one of the most important health problems in the world. It affects more than 300 million humans and according to the WHO these numbers will continue growing during the next 15 years /23/. Recent epidemiological data on obesity regarding distinct regions of the world can Accepted: 18 May, 2009 Reprint address: Licio A. Velloso DCM -FCM, UN1CAMP 13084-970 Campinas SP, Brazil e-mail: lavelloso@fcm.unicamp.br be found at www.iuns.org/features/obesity/tabfig. htm.
Except for some rare types of monogenic defects /16/, obesity occurs due to the complex combination of multiple environmental and genetic factors /20/. The consumption of highly energetic and palatable foods is amongst the most important epidemiological factors predisposing to this disease /20/. However, not all people exposed to this type of diet develop obesity, and this fact has long intrigued researchers. As currently known, the main reason for the protective phenotype is the intrinsic capacity to maintain the homeostatic control of energy stores in the body /20/. Specialized neurons of the hypothalamus play a central role, connecting the information provided by leptin and insulin, regarding the size of peripheral fat depots, with the mechanisms that regulate hunger and thermogenesis /54/. As long as the system is perfectly coupled, changes in energy intake are matched by proportional modifications in energy expenditure. Thus, it is clear that, in order to understand the mechanisms behind most cases of obesity, the phenomena that connect the consumption of highly energetic foods with the loss of energy homeostasis must be deciphered.
A series of recent studies has provided a solid basis to support the hypothesis that in diet-induced obesity, the hypothalamus is targeted by an inflammatory process that leads to defective regulation of energy homeostasis /13,32,58,607. In the present review, to discuss this complex mechanism, we start by presenting the physiological role of the hypothalamus in the control of food intake and energy expenditure. Next, we discuss how nutrients can disrupt the correct functioning of this highly specialized organ. Finally, we present the mechanisms involved in diet-induced hypothalamic resistance to adipostatic signals. VOLUME 20, NO. 5-6, 2009 
HYPOTHALAMIC CONTROL OF FEEDING AND ENERGY EXPENDITURE
Two distinct subpopulations of neurons of the arcuate nucleus of the hypothalamus act as the sensors for the energy stores in the body and coordinate a complex network of neurons that, in due course, control the balance of hunger versus satiety, and pro-versus anti-thermogenesis /19.48/. These first-order neurons are equipped with receptors and intracellular molecular systems capable of detecting subtle or chronic changes in the levels of hormones and nutrients present in the bloodstream /48/. The response to these changes is based on the modulation of the firing rate and of neurotransmitter production and release by specific neuron bodies 1221.
The subpopulations of neurons of the arcuate nucleus are characterized by the neurotransmitters each one produces. One of the subpopulations expresses the orexigenic peptides, NPY and AgRP, while the other expresses the anorexigenic POMC (α-MSH) and CART 722,487 (Fig. 1) . Both subpopulations project to the lateral (LH) and paraventricular (PVN) nuclei of the hypothalamus where they control the functions of second-order neurons. In the PVN, two distinct subpopulations of neurons produce the anorexigenic and prothermogenic neurotransmitters, TRH and CRH 7117, while in the LH, two other subpopulations produce the predominantly orexigenic neurotransmitter orexin and the predominantly anti-thermogenic MCH 7117 (Fig. 1) . During fasting or when body energy stores are depleted, the expressions of NPY and AgRP are induced, while POMC and CART are inhibited. This coordinated response is dependent on the simultaneous sensing of decreased nutrient availability, reduced levels of the adipostatic hormones leptin and insulin, reduced levels of the gut hormones CCK, GLP-1 and GIF, and increased levels of the gastric hormone ghrelin 737. Active NPY/AgRPergic neurons send inhibitory projections to the PVN, reducing the expressions of TRH and CRH, and stimulatory projections to the LH, boosting the activities of the orexin and MCH expressing neurons. Conversely, following a meal, or when body energy stores are replenished, NPY/ AgRPergic neurons are inhibited, and POMC/ CARTergic neurons are active. In this context, nutrient availability and the levels of leptin and insulin are increased, as well as the levels of CCK, GLP-1 and GIP. Conversely, the level of ghrelin is reduced. The result is the inhibition of orexin and MCH neurons in the LH and the activation of the CRH and TRH neurons in the PVN 73,11.22/.
The mechanisms by which second-order neurons effectively control food intake and energy expenditure are under intense investigation. MCH neurons play an important role in the control of energy expenditure /11,407. Increased expression of this neurotransmitter restrains animal motility and reduces the expression of the mitochondrial uncoupling protein, UCP1, in brown adipose tissue, together leading to a reduction in energy output 711, 407. Conversely, knockout of MCH produces a lean phenotype, due to a combined effect on feeding and thermogenesis 744,507, while knockout of the main MCH receptor, MCHR1, produces a lean phenotype, predominantly due to increased energy expenditure 73 O/. Orexin has a predominant role in arousal and the control of feeding /9,177. Injection of this neurotransmitter into the hypothalamus generates a potent orexigenic stimulus; however, little is known about the mechanisms behind this response /17/. In opposition to the neurotransmitters of the LH, the PVN neurotransmitters, TRH and CRH, have rather overlapping roles in the control of hunger and thermogenesis 72,47/. TRH biosynthesis and release is controlled by multiple inputs coming from POMC neurons, direct leptin signals, and from other sources such as T3 7187. Although most studies have explored the role of TRH in the control of thyroid function and, consequently, on thermogenesis, there are plenty of data showing its direct action in the control of feeding 753/. Similarly to TRH, CRH production is modulated by a number of different inputs, such as signals emanating from the arcuate nucleus and direct actions of leptin, GLP-1 and histamine /37, 457. The reduction of appetite is the most studied effect of CRH, but several studies point to its prothermogenic effects as well /51/. However, little is known about the mechanisms controlling these phenomena. Some additional pathways of the central nervous system play modulatory roles in energy balance. The connections of first-and second-order neurons of the hypothalamus with these systems are only beginning to be deciphered /22/. The actions of serotonin and norepinephrine to induce satiety and increase energy expenditure have been known for a long time /25,56/. Nevertheless, these neurotransmitters play rather unspecific and minor regulatory roles in this context, as shown by the moderate/severe adverse effects produced by drugs acting through the control of these neurotransmitters and by the limited efficiency of all treatment regimens employing such drugs 1261. Recently, a new player came onto the scene. The development of drugs that interact with the receptor for the endogenous cannabinoid system revealed an additional mechanism for the control of food intake and thermogenesis. The first clues about the orexigenic properties of the endogenous cannabinoid system came from the observation that the consumption of exogenous cannabinoids present in marijuana produced a powerful sensation of hunger /15/. The characterization of the main endocannabinoid receptor, CB1, and the development of synthetic antagonists for this receptor created hope for the production of new, safer and more effective drugs for the treatment of obesity /15/. However, clinical data show that the weight loss produced by this class of drug is only marginally superior to that produced by serotonin re-uptake inhibitors, and adverse affects, such as depression and increased rate of suicide, have precluded the widespread use of these compounds for the treatment of obesity /55/.
Although, as discussed above, a number of mechanisms play a role in the control of hypothalamic neurons involved in the regulation of energy homeostasis, leptin and insulin are regarded as the most robust peripheral signal providers to the hypothalamus /48/. Leptin is produced predominantly by the adipose tissue in direct proportion to body fat mass /36/, and although some peripheral actions have been attributed to this hormone, such VOLUME 20, NO. [5] [6] 2009 as the regulation of insulin production by pancreatic ß-cells 7497, modulation of insulin action 747, and control of a number of immune functions 727,317, the basomedial hypothalamus, particularly the arcuate nucleus, is the main site of its action 736,487.
Both NPY/AgRPergic and POMC/CARTergic neurons express high levels of the main form of the ObR SOCS3 JNK IKK PTP1B
Diet and other inflammatory factors leptin receptor, the ObRb 736,487 (Fig. 2 ). This is a monomeric transmembrane protein that belongs to the type I cytokine receptor family 735,367. Like the other members of this family, ObRb lacks intrinsic enzymatic activity and depends on at least one associated kinase, JAK2, to transduce its signal 7357. Upon leptin binding to ObRb, dimerization of receptor units accompanies JAK2 autophosphorylation and the tyrosine phosphorylation of two residues (Tyr985 and Tyrl 138) in the receptor itself 7357. These events generate the possibility of activation of at least three distinct intracellular signaling pathways 7357. Tyrosine phosphorylation of Tyr985 recruits the tyrosine phosphatase SHP2, which mediates the activation of the p21ras/ERK signaling pathway 735,367. Tyrosine phosphorylation of Tyrl 138 recruits STAT3 to the ObRb, leading to STAT3 tyrosine phosphorylation and translocation to the nucleus, providing a fast track for leptin-induced control of gene expression 7367. Finally, the autophosphorylation of JAK2 leads to the recruitment and tyrosine phosphorylation of adaptor proteins IRS 1/2, which promotes the activation of PI3-kinase and its downstream signaling 7367. It is possible that several other signaling pathways are also activated through the ObRb; these may include other substrates for JAK2, since a large number of Tyr residues may be phosphorylated following kinase activation, and the engagement of as yet unknown tyrosine kinases, since signal transduction through IRS17PI3-kinase/ Akt can occur even in the absence of the activation ofJAK2/277. Each of the signaling pathways controlled by leptin play a role in a specific compartment of the complex response to this hormone. In POMC7 CARTergic neurons, the activation of JAK2/STAT3 signaling by leptin leads to increased transcriptional activity, boosting the expression of POMC 711,487. This effect is enhanced by simultaneous insulin action, but apparently not reproduced by insulin alone 787. Conversely, the activation of PI3 kinase activity seems to play a minor role in the control of neurotransmitter expression, but is essential for neurotransmitter release in the synaptic terminals. This effect is achieved through the control of neuronal firing rate. Once activated by either leptin or insulin, PI3 kinase mediates neuronal depolariza-tion by inhibiting ATP-sensitive potassium channels /22,38/. The central role for PI3 kinase in this context is further shown by the fact that genetic or pharmacological modulations of phosphatases that control the signaling through PI3 kinase, such as PTEN and 5'-ptase IV, have profound effects on feeding behavior /5,42/.
Since not only POMC/CARTergic neurons, but also the orexigenic NPY/AgRPergic neurons harbor the leptin receptor, an important question was raised regarding the mechanisms by which leptin can simultaneously activate the anorexigenic neurons, while inhibiting the orexigenic neurons. The answer to this question came from the demonstration that POMC/CARTergic neurons project inhibitory fibers to NPY/AgRPergic neurons. When leptin levels are high, the activation of POMC/ CARTergic neurons leads to simultaneous inhibition of NPY/AgRPergic neurons, a phenomenon that superimposes the direct signals eventually generated through the ObRb, and also the insulin receptor present in these orexigenic neurons 1111.
Finally, it is important to mention that, besides its predominant actions in the arcuate nucleus, a number of studies have shown that leptin can act through cells present in other regions of the brain. Some of these cells may act only to modulate the main signals delivered by arcuate nucleus neurons, but in some cases specific responses may control other physiological phenomena primarily controlled by leptin /21/.
Insulin is the second most important adipostatic signal provider to the hypothalamus. Studies from the late 1960s pioneered the investigation into the roles of insulin in the central nervous system 1291. However, only after the identification of leptin in 1994 were the functions of insulin in the hypothalamus described /1,8/. In the arcuate nucleus, both NPY/AgRPergic and POMC/CARTergic neurons express receptors for insulin /48,54/. As in peripheral tissues, in the hypothalamus, insulin activates signal transduction through IRS1 and IRS2, leading to the engagement of the PI3K/Akt/ Foxol pathway /8,48,52/. In addition, insulin induces potent cross-talk with the leptin signaling pathway by the activation of JAK2 /8/. One of the most important functions of insulin in the hypothalamus is to enhance leptin's signal /8,48/. In the absence of the insulin signal in the hypothalamus, much of the adipostatic function of leptin is lost, as demonstrated using neuron-specific insulin receptor knockout mice /?/.
Therefore, under physiological conditions the hypothalamus, acting under the control of peripheral factors, coordinates perfect coupling between food intake and energy expenditure. As long as the system is fully active, body mass is maintained steady.
NUTRIENT-INDUCED DYSFUNCTION OF THE HYPOTHALAMUS
Excessive caloric intake, regardless of the type of nutrient consumed, is a primary risk factor for the development of obesity /10/. However, a number of epidemiological studies have shown that populations consuming preferentially diets rich in fat are especially prone to gain body mass 712,397. hi addition to its caloric value, fatty acids are known to exert functional modulation of several tissues and cell types. Therefore, we tested the hypothesis that high fat consumption could modulate gene expression in the hypothalamus. Using a macroarray approach, the expressions of more than 1,000 hypothalamic genes were evaluated simultaneously. More than 15% of the analyzed genes were somehow modulated by the diet. Clustering the genes by function revealed that immune response related genes were the most affected /13,14/. Among the fatty acids commonly present in the occidental diet, the long-chain saturated ones are the most harmful. By activating signal transduction through receptors of the tolllike receptor family, especially TLR4, these fatty acids activate an inflammatory response by the microglia cells in the hypothalamus 7327. Signaling through INK and ΝΡκΒ leads to the induction of cytokine gene transcription, and local levels of TNF-α, IL-l , IL-6 and IFN-γ induce and maintain hypothalamic inflammation 7327.
Following fatty acid-induced activation of TLR4 signaling, cells turn on an adaptive mechanism that has the biological purpose of adapting protein synthesis to the damage imposed by inflammation. This mechanism is called endoplasmic reticulum stress and, depending on the magnitude and duration of the damage, can enhance inflammatory signaling or induce apoptosis 1591.
The ER is the organelle responsible for the synthesis and processing of membrane and secretory proteins /57/. When ER homeostasis is disrupted, accumulation of misfolded and unfolded proteins in the ER lumen ensues /46,57/. To deal with this condition, the affected cells activate a complex signaling system known as the unfolded protein response (UPR), aimed at preserving cell integrity, while the harmful condition persists 746, 577. One of the outcomes of the activation of UPR is the induction of the expression of cytokines and proteins involved in immune surveillance 724,287.
If the exposure to saturated fatty acids is prolonged and, depending on some as yet unknown genetic determinants, a pro-apototic response is induced, this leads to the preferential loss of anorexigenic neurons in the arcuate nucleus 7337. As time passes, a gradual modification in the relative numbers of orexigenic and anorexigenic neurons takes place and a new set point for body adiposity is generated. This fact may explain why some obese patients are so resistant to the different behavioral and pharmacological approaches employed to treat obesity. Thus, activation of TLR4 signal transduction, followed by the induction of hypothalamic ER stress, are the main mechanisms linking the high consumption of dietary fats to the induction of hypothalamic dysfunction in obesity.
HYPOTHALAMIC RESISTANCE TO ANOREXIGENIC SIGNALS
As long as a perfect coupling between caloric intake and energy expenditure is preserved, body adiposity is maintained at a physiological level /107. One of the mechanisms involved in the breakdown of this equilibrium is the installation of resistance to the anorexigenic and' thermogenic effects of leptin and insulin 7137. In animal models, the resistance to both these hormones can be quantified by a simple method. In intracerebroventricular cannulated lean rodents, the acute injection of leptin leads to a reduction of up to 60% of spontaneous food intake over 12 h 787. Injecting insulin, rather then leptin, produces a reduction of up to 50% in food intake. However, if the same tests are performed in obese animals, the effects of both hormones are blunted by at least 50%. To identify the molecular mechanism responsible for producing the functional resistance to leptin and insulin, several groups have evaluated, different models of obesity, and the most remarkable findings reveal that, upon diet-induced obesity, the induction of inflammatory activity, specifically in the hypothalamus, leads to the activation of intracellular signaling pathways that promote a negative cross-talk with the leptin and insulin signaling systems, thus impairing their physiological anorexigenic activities 78,527.
Currently, four distinct mechanisms are known to play a role in diet-and cytokine-induced resistance to leptin and/or insulin in the hypothalamus of rodents. Both TNF-a and the consumption of fat-rich diets can induce the activation of the serine-kinase JNK in hypothalamic cells. Activated JNK targets IRS1, catalyzing its serine phosphorylation and hampering its capacity to act appropriately as a docking protein for PI3-kinase. This results in reduced insulin-induced activation of Akt and coincides with functional resistance to insulin. Inhibition of JNK by a specific chemical inhibitor or inhibition of TNF-α by a blocking monoclonal antibody reverses the effects of the diet or the cytokine and re-establishes a normal tonus for insulin activity in the hypothalamus 7137.
IKK, the serine kinase involved in IkB phosphorylation/degradation, which leads to NFicB activation, is another intermediary involved in dietinduced insulin resistance in the hypothalamus 7607. In rats fed on a fat-rich diet, activated IKK promoted the serine phosphorylation of IRS1, hampering the signal transduction of insulin. Whilst hi peripheral organs of insulin resistant animals, the inhibition of IKK by salicylates was proven to reinstall correct insulin activity 7437, no data regarding the pharmacological inhibition of this enzyme in the hypothalamus is available so far, but it is expected to work in a similar manner.
SOCS3 belongs to a family of inducible proteins that respond to stimulation by a number of cytokines, hormones and growth factors. Once expressed, SOCS proteins provide negative feedback to the original signal, acting as a regulatory loop to restrain overstimulation. In diet-induced obesity, the expression of SOCS3 is significantly stimulated in the hypothalamus, providing a negative control for leptin and insulin signaling /6,34/. At least two mechanisms are involved in SOCS3 inhibition of leptin and insulin signaling. The first depends on the physical interaction of SOCS3 with either ObRb or STAT3 1361. Under these circumstances, the transduction of the signal is inhibited because the sites for protein-protein interaction are blocked by SOCS3. The second mechanism depends on SOCS3-dependent ubiquitination of IRS proteins. Following ubiquitin tagging, IRS proteins are directed to proteosomic degradation, restraining signal transduction through this pathway 7367. The important role for SOCS3 in diet-induced obesity is further confirmed by the fact that genetic abrogation of SOCS3 is capable of protecting mice from diet-induced obesity 7367.
An additional mechanism involved in diet-and cytokine-induced resistance to anorexigenic signaling in the hypothalamus is the induction of expression of the tyrosine phosphatase FTP IB. Once induced, this enzyme catalyses the dephosphorylation of the IR and IRS proteins, turning off the signals generated by insulin. Knockout of the FTP IB gene or knockdown of FTP IB by antisense oligonucleotides protects experimental animals from diet-and cytokine-induced insulin resistance in the hypothalamus 7417.
CONCLUDING REMARKS
Following the identification of leptin 15 years ago, great advances have occurred in understanding the physiological mechanisms of body mass control. This has allowed substantial advance in the characterization of the mechanisms involved in the development of obesity. It is currently believed that, in most cases of obesity, the hypothalamus is the primarily affected organ. Upon high consumption of dietary fat, a local inflammatory process is triggered by the activation of TLR4 signaling. Neurons and microglia are affected and ER stress is induced. Depending on genetic background, specific subpopulations of neurons are lost by apoptosis, therefore enhancing the harmful effects of inflammation. With time, the homeostatic control of body energy stores is lost and obesity emerges. Future studies will focus on the characterization of similar phenomena in human beings and on the evaluation of specific anti-inflammatory approaches to treat obesity.
